CIRM - Centre Interdisciplinaire de Recherche sur le Médicament - ULiège CESAM - Complex and Entangled Systems from Atoms to Materials - ULiège GIGA Molecular Biology of Diseases-Gene Expression & Cancer CERM - Center for Education and Research on Macromolecules - ULiège
Disciplines :
Pharmacy, pharmacology & toxicology
Author, co-author :
Berger, Manon ✱; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM) ; Université de Liège - ULiège > Département de pharmacie > Développement de nanomédicaments
Toussaint, François ✱; University of Liège [ULiège] - Complex and Entangled Systems from Atoms to Materials [CESAM] - Research Unit, Center for Education and Research on Macromolecules [CERM] - Belgium
Djemaa, Sanaa Ben ✱; Gene Expression and Cancer Laboratory (GEC), GIGA-Molecular Biology of Diseases, University of Liège, Belgium
Laloy, Julie; NNC Laboratory (NARILIS), Department of Pharmacy, University of Namur, Belgium
Evrard, Brigitte ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Jérôme, Christine ; University of Liège [ULiège] - Complex and Entangled Systems from Atoms to Materials [CESAM] - Research Unit, Center for Education and Research on Macromolecules [CERM] - Belgium
Lechanteur, Anna ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique ; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM)
Mottet, Denis ✱; Université de Liège - ULiège > GIGA > GIGA Molecular Biology of Diseases - Gene Expression & Cancer
Debuigne, Antoine ✱; University of Liège [ULiège] - Complex and Entangled Systems from Atoms to Materials [CESAM] - Research Unit, Center for Education and Research on Macromolecules [CERM] - Belgium
Piel, Géraldine ✱; Université de Liège - ULiège > Unités de recherche interfacultaires > Centre Interdisciplinaire de Recherche sur le Médicament (CIRM) ; Université de Liège - ULiège > Département de pharmacie > Développement de nanomédicaments
✱ These authors have contributed equally to this work.
Language :
English
Title :
Poly(vinyl pyrrolidone) derivatives as PEG alternatives for stealth, non-toxic and less immunogenic siRNA-containing lipoplex delivery.
Verbeke, R., Lentacker, I., De Smedt, S.C., Dewitte, H., The dawn of mRNA vaccines: the COVID-19 case. J. Control. Release 333 (2021), 511–520, 10.1016/j.jconrel.2021.03.043.
Schoenmaker, L., Witzigmann, D., Kulkarni, J.A., Verbeke, R., Kersten, G., Jiskoot, W., Crommelin, D.J.A., mRNA-lipid nanoparticle COVID-19 vaccines: structure and stability. Int. J. Pharm., 601, 2021, 120586, 10.1016/j.ijpharm.2021.120586.
Berger, M., Lechanteur, A., Evrard, B., Piel, G., Innovative lipoplexes formulations with enhanced siRNA efficacy for cancer treatment: where are we now?. Int. J. Pharm., 605, 2021, 10.1016/j.ijpharm.2021.120851.
Rüger, J., Ioannou, S., Castanotto, D., Stein, C.A., Oligonucleotides to the (gene) rescue: FDA approvals 2017–2019. Trends Pharmacol. Sci. 41 (2020), 27–41, 10.1016/j.tips.2019.10.009.
Hu, B., Zhong, L., Weng, Y., Peng, L., Huang, Y., Zhao, Y., Liang, X.J., Therapeutic siRNA: state of the art. Signal Transduct. Target. Ther., 5, 2020, 10.1038/s41392-020-0207-x.
Berger, M., Degey, M., Leblond Chain, J., Maquoi, E., Evrard, B., Lechanteur, A., Piel, G., Effect of PEG anchor and serum on lipid nanoparticles: development of a nanoparticles tracking method. Pharmaceutics, 15, 2023, 10.3390/pharmaceutics15020597.
Suk, J.S., Xu, Q., Kim, N., Hanes, J., Ensign, L.M., PEGylation as a strategy for improving nanoparticle-based drug and gene delivery. Adv. Drug Deliv. Rev. 99 (2016), 28–51, 10.1016/j.addr.2015.09.012.
Sakurai, Y., Hatakeyama, H., Sato, Y., Hyodo, M., Akita, H., Harashima, H., Gene silencing via RNAi and siRNA quantification in tumor tissue using MEND, a liposomal siRNA delivery system. Mol. Ther. 21 (2013), 1195–1203, 10.1038/mt.2013.57.
Son, K., Ueda, M., Taguchi, K., Maruyama, T., Takeoka, S., Ito, Y., Evasion of the accelerated blood clearance phenomenon by polysarcosine coating of liposomes. J. Control. Release 322 (2020), 209–216, 10.1016/j.jconrel.2020.03.022.
Francia, V., Schiffelers, R.M., Cullis, P.R., Witzigmann, D., The biomolecular Corona of lipid nanoparticles for gene therapy. Bioconjug. Chem. 31 (2020), 2046–2059, 10.1021/acs.bioconjchem.0c00366.
Nguyen, V.H., Lee, B.J., Protein corona: a new approach for nanomedicine design. Int. J. Nanomedicine 12 (2017), 3137–3151, 10.2147/IJN.S129300.
Hattori, Y., Tamaki, K., Sakasai, S., Ozaki, K.I., Onishi, H., Effects of PEG anchors in PEGylated siRNA lipoplexes on in vitro gene-silencing effects and siRNA biodistribution in mice. Mol. Med. Rep. 22 (2020), 4183–4196, 10.3892/mmr.2020.11525.
Kozma, G.T., Shimizu, T., Ishida, T., Szebeni, J., Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals. Adv. Drug Deliv. Rev. 154–155 (2020), 163–175, 10.1016/j.addr.2020.07.024.
De Vrieze, J., Suspicions grow that nanoparticles in Pfizer's COVID-19 vaccine trigger rare allergic reactions. Science, 2020, 10.1126/science.abg2359 (80-.).
Thi, T.T.H., Pilkington, E.H., Nguyen, D.H., Lee, J.S., Park, K.D., Truong, N.P., The importance of poly(ethylene glycol) alternatives for overcoming PEG immunogenicity in drug delivery and bioconjugation. Polymers (Basel), 12, 2020, 10.3390/polym12020298.
Abu Lila, A.S., Nawata, K., Shimizu, T., Ishida, T., Kiwada, H., Use of polyglycerol (PG), instead of polyethylene glycol (PEG), prevents induction of the accelerated blood clearance phenomenon against long-circulating liposomes upon repeated administration. Int. J. Pharm. 456 (2013), 235–242, 10.1016/j.ijpharm.2013.07.059.
Kierstead, P.H., Okochi, H., Venditto, V.J., Chuong, T.C., Kivimae, S., Fréchet, J.M.J., Szoka, F.C., The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes. J. Control. Release 213 (2015), 1–9, 10.1016/j.jconrel.2015.06.023.
Nag, O.K., Awasthi, V., Surface engineering of liposomes for stealth behavior. Pharmaceutics 5 (2013), 542–569, 10.3390/pharmaceutics5040542.
Luo, Y., Hong, Y., Shen, L., Wu, F., Lin, X., Multifunctional role of polyvinylpyrrolidone in pharmaceutical formulations. AAPS PharmSciTech, 22, 2021, 10.1208/s12249-020-01909-4.
Hwang, D., Ramsey, J.D., Kabanov, A.V., Polymeric micelles for the delivery of poorly soluble drugs: from nanoformulation to clinical approval. Adv. Drug Deliv. Rev. 156 (2020), 80–118, 10.1016/j.addr.2020.09.009.
Kurakula, M., Rao, G.S.N.K., Pharmaceutical assessment of polyvinylpyrrolidone (PVP): as excipient from conventional to controlled delivery systems with a spotlight on COVID-19 inhibition. J. Drug Deliv. Sci. Technol., 60, 2020, 102046, 10.1016/j.jddst.2020.102046.
Torchilin, V., Levchenko, T., Whiteman, K., Yaroslavov, A., Tsatsakis, A., Rizos, A., Michailova, E., Shtilman, M., Amphiphilic poly-N-vinylpyrrolidones: synthesis, properties and liposome surface modification. Biomaterials 22 (2001), 3035–3044, 10.1016/s0142-9612(01)00050-3.
Liu, Y., Luo, X., Xu, X., Gao, N., Liu, X., Preparation, characterization and in vivo pharmacokinetic study of PVP-modified oleanolic acid liposomes. Int. J. Pharm. 517 (2017), 1–7, 10.1016/j.ijpharm.2016.11.056.
Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Hubert, P., Piel, G., Development of anti-E6 pegylated lipoplexes for mucosal application in the context of cervical preneoplastic lesions. Int. J. Pharm. 483 (2015), 268–277, 10.1016/j.ijpharm.2015.02.041.
Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Piel, G., Hubert, P., Promoting vaginal distribution of E7 and MCL-1 siRNA-silencing nanoparticles for cervical cancer treatment. Mol. Pharm. 14 (2017), 1706–1717, 10.1021/acs.molpharmaceut.6b01154.
Lechanteur, A., Furst, T., Evrard, B., Delvenne, P., Hubert, P., Piel, G., PEGylation of lipoplexes: the right balance between cytotoxicity and siRNA effectiveness. Eur. J. Pharm. Sci. 93 (2016), 493–503, 10.1016/j.ejps.2016.08.058.
Furst, T., Dakwar, G.R., Zagato, E., Lechanteur, A., Remaut, K., Evrard, B., Braeckmans, K., Piel, G., Freeze-dried mucoadhesive polymeric system containing pegylated lipoplexes: towards a vaginal sustained released system for siRNA. J. Control. Release 236 (2016), 68–78, 10.1016/j.jconrel.2016.06.028.
Furst, T., Bettonville, V., Farcas, E., Frere, A., Lechanteur, A., Evrard, B., Fillet, M., Piel, G., Servais, A.C., Capillary electrophoresis method to determine siRNA complexation with cationic liposomes. Electrophoresis 37 (2016), 2685–2691, 10.1002/elps.201600249.
Mechler, A., Praporski, S., Atmuri, K., Boland, M., Separovic, F., Martin, L.L., Specific and selective peptide-membrane interactions revealed using quartz crystal microbalance. Biophys. J. 93 (2007), 3907–3916, 10.1529/biophysj.107.116525.
John, T., Voo, Z.X., Kubeil, C., Abel, B., Graham, B., Spiccia, L., Martin, L.L., Effects of guanidino modified aminoglycosides on mammalian membranes studied using a quartz crystal microbalance. Medchemcomm 8 (2017), 1112–1120, 10.1039/c7md00054e.
Karim, R., Palazzo, C., Laloy, J., Delvigne, A.S., Vanslambrouck, S., Jerome, C., Lepeltier, E., Orange, F., Dogne, J.M., Evrard, B., Passirani, C., Piel, G., Development and evaluation of injectable nanosized drug delivery systems for apigenin. Int. J. Pharm. 532 (2017), 757–768, 10.1016/j.ijpharm.2017.04.064.
Laloy, J., Minet, V., Alpan, L., Mullier, F., Beken, S., Toussaint, O., Lucas, S., Dogné, J.M., Impact of silver nanoparticles on haemolysis, platelet function and coagulation. Nanobiomedicine 1 (2014), 1–9, 10.5772/59346.
Zard, S.Z., Discovery of the RAFT/MADIX process: mechanistic insights and polymer chemistry implications. Macromolecules 53 (2020), 8144–8159, 10.1021/acs.macromol.0c01441.
Perrier, S., 50th anniversary perspective: RAFT polymerization - a user guide. Macromolecules 50 (2017), 7433–7447, 10.1021/acs.macromol.7b00767.
Roka, N., Kokkorogianni, O., Kontoes-Georgoudakis, P., Choinopoulos, I., Pitsikalis, M., Recent advances in the synthesis of complex macromolecular architectures based on poly(N-vinyl pyrrolidone) and the RAFT polymerization technique. Polymers (Basel), 14, 2022, 10.3390/polym14040701.
Tilottama, B., Manojkumar, K., Haribabu, P.M., Vijayakrishna, K., A short review on RAFT polymerization of less activated monomers. J. Macromol. Sci. Part A Pure Appl. Chem. 59 (2022), 180–201, 10.1080/10601325.2021.2024076.
Pound, G., McKenzie, J.M., Lange, R.F.M., Klumperman, B., Polymer-protein conjugates from ω-aldehyde endfunctional poly(N-vinylpyrrolidone) synthesised via xanthate-mediated living radical polymerisation. Chem. Commun., 2008, 3193–3195, 10.1039/b803952f.
Langlais, M., Coutelier, O., Destarac, M., Thiolactone-functional reversible deactivation radical polymerization agents for advanced macromolecular engineering. Macromolecules 51 (2018), 4315–4324, 10.1021/acs.macromol.8b00770.
Destarac, M., Kalai, C., Wilczewska, A., Petit, L., Van Gramberen, E., Zard, S.Z., Various strategies for the chemical transformation of xanthate-functional chain termini in MADIX copolymers. ACS Symp. Ser. 944 (2006), 564–577, 10.1021/bk-2006-0944.ch038.
Xia, Y., Tian, J., Chen, X., Effect of surface properties on liposomal siRNA delivery. Biomaterials 79 (2016), 56–68, 10.1016/j.biomaterials.2015.11.056.
Dixon, M.C., Quartz crystal microbalance with dissipation monitoring: enabling real-time characterization of biological materials and their interactions. J. Biomol. Tech. 19 (2008), 151–158.
Sauerbrey, G., Verwendung von Schwingquarzen zur Wägung dünner Schichten und zur Mikrowägung. Z. Phys. 155 (1959), 206–222, 10.1007/BF01337937.
Jia, H.R., Zhu, Y.X., Duan, Q.Y., Chen, Z., Wu, F.G., Nanomaterials meet zebrafish: toxicity evaluation and drug delivery applications. J. Control. Release 311–312 (2019), 301–318, 10.1016/j.jconrel.2019.08.022.
Lee, K.Y., Jang, G.H., Byun, C.H., Jeun, M., Searson, P.C., Lee, K.H., Zebrafish models for functional and toxicological screening of nanoscale drug delivery systems: promoting preclinical applications. Biosci. Rep. 37 (2017), 1–13, 10.1042/BSR20170199.
Ledoux, A., St-Gelais, A., Cieckiewicz, E., Jansen, O., Bordignon, A., Illien, B., Di Giovanni, N., Marvilliers, A., Hoareau, F., Pendeville, H., Quetin-Leclercq, J., Frédérich, M., Antimalarial activities of alkyl cyclohexenone derivatives isolated from the leaves of Poupartia borbonica. J. Nat. Prod. 80 (2017), 1750–1757, 10.1021/acs.jnatprod.6b01019.
Sieber, S., Grossen, P., Uhl, P., Detampel, P., Mier, W., Witzigmann, D., Huwyler, J., Zebrafish as a predictive screening model to assess macrophage clearance of liposomes in vivo. Nanomed. Nanotechnol. Biol. Med. 17 (2019), 82–93, 10.1016/j.nano.2018.11.017.
Ben Djemaa, S., Munnier, E., Chourpa, I., Allard-Vannier, E., David, S., Versatile electrostatically assembled polymeric siRNA nanovectors: can they overcome the limits of siRNA tumor delivery?. Int. J. Pharm., 567, 2019, 10.1016/j.ijpharm.2019.06.023.
Dominska, M., Dykxhoorn, D.M., Breaking down the barriers: siRNA delivery and endosome escape. J. Cell Sci. 123 (2010), 1183–1189, 10.1242/jcs.066399.
Reischl, D., Zimmer, A., Drug delivery of siRNA therapeutics: potentials and limits of nanosystems. Nanomed. Nanotechnol. Biol. Med. 5 (2009), 8–20, 10.1016/J.NANO.2008.06.001.
Videira, M., Arranja, A., Rafael, D., Gaspar, R., Preclinical development of siRNA therapeutics: towards the match between fundamental science and engineered systems. Nanomed. Nanotechnol. Biol. Med. 10 (2014), 689–702, 10.1016/j.nano.2013.11.018.
Kanamala, M., Palmer, B.D., Ghandehari, H., Wilson, W.R., Wu, Z., PEG-benzaldehyde-hydrazone-lipid based PEG-sheddable pH-sensitive liposomes: abilities for endosomal escape and long circulation. Pharm. Res. 35 (2018), 1–13, 10.1007/S11095-018-2429-Y/TABLES/4.
Takeuchi, I., Kanno, Y., Uchiro, H., Makino, K., Polyborane-encapsulated PEGylated liposomes prepared using post-insertion technique for boron neutron capture therapy. J. Oleo Sci. 68 (2019), 1261–1270, 10.5650/JOS.ESS19218.
Weber, C., Voigt, M., Simon, J., Danner, A.K., Frey, H., Mailänder, V., Helm, M., Morsbach, S., Landfester, K., Functionalization of liposomes with hydrophilic polymers results in macrophage uptake independent of the protein corona. Biomacromolecules 20 (2019), 2989–2999, 10.1021/ACS.BIOMAC.9B00539/SUPPL_FILE/BM9B00539_SI_002.XLSX.
Bachir, Z.A., Huang, Y.K., He, M.Y., Huang, L., Hou, X.Y., Chen, R.J., Gao, F., Effects of PEG surface density and chain length on the pharmacokinetics and biodistribution of methotrexate-loaded chitosan nanoparticles. Int. J. Nanomedicine 13 (2018), 5657–5671, 10.2147/IJN.S167443.
Elsabahy, M., Wooley, K.L., Cytokines as biomarkers of nanoparticle immunotoxicity. Chem. Soc. Rev. 42 (2013), 5552–5576, 10.1039/c3cs60064e.
Bigini, P., Gobbi, M., Bonati, L., Clavenna, A., Zucchetti, M., Garattini, S., Pasut, G., The role and impact of polyethylene glycol on anaphylactic reactions to COVID-19 nano-vaccines. Nat. Nanotechnol. 16 (2021), 1164–1168, 10.1038/s41565-021-01001-3.
